Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts
about
Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survivalStructural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2.Mesenchymal migration as a therapeutic target in glioblastoma.Targeting Pyk2 for therapeutic interventionThe Pyk2 FERM regulates Pyk2 complex formation and phosphorylationmiRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinaseTROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.The Pyk2 FERM domain as a target to inhibit glioma migration.Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.Emerging insights into the molecular and cellular basis of glioblastoma.A Novel Interaction between Pyk2 and MAP4K4 Is Integrated with Glioma Cell MigrationSystematic review of protein biomarkers of invasive behavior in glioblastoma.Gliomas and seizures.Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation.
P2860
Q24313400-2A327DC4-EAB8-4339-9E1E-DF3B7DD99E98Q33519129-6AE6E52E-CE8E-4ED0-81BE-81ACE44A63B6Q34002994-B887361F-A459-471D-A70E-BCD9BD989392Q34146883-CE4D21A5-A381-408D-ADD8-6C035BFA1E67Q34209351-09571EFD-45A9-4C70-BF24-D538E7009729Q34321677-A7CE368D-41A7-464E-85D2-B621FC5CE60AQ34631652-F4DA66D2-6B73-4A3F-9FF0-20D05B54AFA3Q34974464-3C7035D4-1148-4F5D-BBAF-25D9607E11D1Q35234199-0BABC3A6-CAD8-46BF-BC46-B86B1D548FE1Q35670813-84A6932E-147F-4727-BCFE-65680E150E9BQ35914897-C314B5F5-A219-4736-8275-FFB01A93F491Q37218700-3458F830-865F-4768-A8E7-CA8712A3E7CFQ38165795-D0CDD9BA-81F1-4DE9-87C8-26E92111CBC4Q47147402-74AF7818-546B-464D-A4ED-D52CB1505DB9Q54197365-AE2141DB-4C49-47D6-A60C-BF9AB60CC7CB
P2860
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts
@en
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts.
@nl
type
label
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts
@en
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts.
@nl
prefLabel
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts
@en
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts.
@nl
P2093
P2860
P1476
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts
@en
P2093
Carole Viso
Christopher A Lipinski
Jean Kloss
Joseph C Loftus
Michael E Berens
Nhan L Tran
Zhongbo Yang
P2860
P2888
P304
P356
10.1007/S11060-008-9656-8
P577
2008-07-22T00:00:00Z